Corporate | Financial

Symrise extends Executive Board contract of Heinz-Jürgen Bertram
— Supervisory Board once again reaffirms Dr Heinz-Jürgen Bertram as CEO ahead of schedule for a further three years
— Symrise commits to continuity and stability in the Executive Board
— Firm focus on long-term goals: continuation of successful growth course

At its meeting on 1 December, the Supervisory Board of Symrise AG once again extended the contract of Chief Executive Officer Dr Heinz-Jürgen Bertram ahead of schedule. With his confirmation in office until the end of 2025, Symrise is preserving its customary continuity and long-term management approach. Dr Bertram will continue as CEO of Symrise AG for a further three years and will drive forward the profitable growth course of the Group.

“Dr Heinz-Jürgen Bertram has been leading Symrise AG confidently and successfully for more than ten years now. With his entrepreneurial vision, he has further diversified the product portfolio, tapped into high-growth markets and new customer groups, and most recently sovereignly steered the Group through the pandemic. Under his leadership, Symrise AG has developed into one of the 40 largest publicly listed companies in Germany. After 14 successful years in the MDAX, the Company was promoted to the DAX, Germany's leading index, this year,” said Michael König, Chairman of the Supervisory Board. “This track record demonstrates once again that Dr Bertram enjoys a high level of trust on the capital market as well as among customers and employees. We are delighted to have won him over for another three years as CEO and to continue our successful and trusting cooperation in the upcoming years.”

By 2025 Symrise intends to drive forward its expansion in high-growth business areas as well as the further development of its own base of natural raw materials with targeted investments. The Company is targeting sales of € 5.5 to € 6 billion by 2025. Organic growth is expected to be between 5 and 7 %. With its favorable product mix and efficiency enhancements, Symrise aims to generate an EBITDA margin in the range of 20 to 23 %.

Dr Heinz-Jürgen Bertram (born in 1958), who has a doctorate in chemistry, has performed in various management functions at the Bayer Group, the Haarmann & Reimer Group and Symrise since 1985. Since 2003, he has held several senior positions with Symrise, and was appointed to the Executive Board in 2006. Since August 2009, he heads the Company's business activities as CEO.